Etizolam or etilaam MD has been used as a form of medicine in India and Japan for treating anxiety, panic attacks, and insomnia. The drug has yet to receive official prescription approval in the United Kingdom, United States, and other countries.
Etilaam MD Effects
Currently, the drug is commonly known to cause:
- Decreased and shallow breathing.
- A temporary halt to fits.
- Some addiction or tolerance (at high doses).
- Loss of coordination.
Etizolam has the potential to cause:
- Short-term memory loss.
- Withdrawal symptoms (including those who have a history taking tranquilizers).
- Decreased concentration.
- Nausea and vomiting.
- Bodily sensations.
Use with Other Drugs
There have been very rare cases when etilaam MD can lead to withdrawal symptoms as a result of taking other drugs that contribute to such occurrences. Fatal deaths are usually experienced to those who take the drug in conjunction with melted or crushed tranquilizers (in the form of capsules or tablets).
Gel capsules have a tendency to collapse blood vessels when injected. Therefore, it’s never recommended to inject the drug via gel capsules as these can block the flow of blood.
Mixing Etizolam with other drugs that depress the nervous system is never advisable since it can amplify its intended effects or worsen the current medical condition.
Etizolam is highly prone to abuse when a user fails to stick within the recommended dosage range. Some users have a tendency to take more than the required amount since their tolerance level of the drug is higher than normal. In most cases, this can lead to higher-than-normal intake for a prolonged period, which can be fatal.
Etiozlam or etilaam MD is currently in the “gray” area of the law in most countries. But in countries like the United States and United Kingdom, the drug has yet to receive for medical use in hospitals and clinics. Researchers and chemists are professionals authorized to study and experiment the drug for research purposes.